What is ProQR Therapeutics BV?
, a clinical-stage biotechnology company, focuses on the discovery and development of novel therapeutic medicines.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
, a clinical-stage biotechnology company, focuses on the discovery and development of novel therapeutic medicines. The company develops an RNA editing platform through its Axiomer RNA editing technology for genetic disorders with unmet needs. The company is listed on the NASDAQ in USA, operating in the Healthcare sector, with a market capitalisation of 199.27M.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.